Differential diagnosis of Entamoeba histolytica (pathogenic) and Entamoeba dispar (nonpathogenic), which are two morphologically identical species of amebae, is essential both for treatment decision and public health knowledge. The study reported here was designed to choose a reference differentiation technique. Stool samples (n ؍ 95) were tested by microscopy, TechLab enzyme-linked immunosorbent assays (ELISAs), and an in-house PCR. The target for the PCR amplification was a small region (135 bp) of the SSU rRNA selected to increase the sensitivity of the test. Sixty-eight specimens tested positive by PCR: 2 for E. histolytica and 66 for E. dispar. For detection of E. dispar, ELISA performance was lower than that of microscopy in this reference context, while PCR was much more sensitive than microscopy. Given the low proportion of E. histolytica cases, test performance for this species is difficult to assess. However, for differentiation, PCR performed well on simulated samples, while ELISA gave a discordant result for one of the two samples PCR positive for E. histolytica during the study. This report also confirms that E. dispar infection is significantly higher among travelers and underlines the possibility of acquiring E. histolytica infection in regions that are not areas of endemicity. Because of its lower sensitivity, the interest of ELISA for Entamoeba detection and differentiation in stools seems questionable in nontropical regions. On the other hand, results suggest that PCR should be useful as a reference test for sensitive differentiation of both species and to contribute to physicians' decision in treatment of E. histolytica-or E. dispar-infected patients.
Amebiasis is an important parasitic disease in humans (18).Entamoeba histolytica and Entamoeba dispar parasitize approximately 10% of the world population, of which 90% are asymptomatic infections. It is estimated, however, that amebiasis causes up to 110,000 deaths a year (15). While the infectious agent was discovered in 1875 by Fedor A. Lösch and the distinction between E. dispar and E. histolytica was first suspected in 1925 (3), the evidence for the dichotomy in two different species, pathogenic (E. histolytica) and nonpathogenic (E. dispar), is relatively recent (5). However, E. dispar and E. histolytica are morphologically indistinguishable from one another. Isoenzyme analysis is considered the "gold standard" for differentiating E. histolytica and E. dispar, but this method is not currently available and not readily usable for routine diagnosis (16). More recently, several studies have been devoted to the development of new techniques either based on monoclonal antibodies (8, 9, 10, 20, 21) or molecular biology methods (1,2,4,6,19,22,23) to successfully distinguish the two species in human feces. Reliable distinction would have a medical impact as until now, both infections are usually treated, whereas only approximately 10% (pathogenic infections) need to be treated. This proportion drops to much lower levels in developed countries, wh...